Essepna 0.51 g (Phenylalanine SOLUTION) 0.51 G

ESSEPNA 0.51 G is an intravenous solution containing phenylalanine, used for specific medical conditions. This product is manufactured by Fresenius Kabi Canada Ltd.

Strength

0.51 G

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ESSEPNA 0.51 G is primarily used to address conditions related to phenylalanine deficiency. Phenylalanine is an essential amino acid that plays a crucial role in the synthesis of proteins and other important molecules in the body. This solution is administered intravenously to ensure adequate levels of phenylalanine in patients who may not be able to obtain it through oral intake.

Side Effects

The effects of ESSEPNA 0.51 G can vary depending on the individual's condition and overall health. Commonly, patients may experience improved protein synthesis and overall metabolic function. However, specific effects can differ, and it is important to monitor for any adverse reactions.

Precautions & Warnings

ESSEPNA 0.51 G should be handled with care and administered under the supervision of a healthcare professional. Patients with known allergies to phenylalanine or any components of the solution should avoid its use. Proper storage and handling instructions should be followed to maintain the integrity of the solution.

Avoid Interactions

ESSEPNA 0.51 G may interact with other medications or supplements, particularly those that affect amino acid metabolism. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain dietary supplements may also influence the effectiveness of this solution.

Frequently Asked Questions

ESSEPNA 0.51 G is used to address conditions related to phenylalanine deficiency, ensuring adequate levels of this essential amino acid.

ESSEPNA 0.51 G is administered intravenously, typically under the supervision of a healthcare professional.

Common effects may include improved protein synthesis and overall metabolic function, though individual responses can vary.

Patients should be aware of potential allergies to phenylalanine and follow proper storage and handling instructions.

Yes, it may interact with medications or supplements that affect amino acid metabolism, so it's important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.